The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from three core laboratories: 1.) pharmacology and…

Ended Awarded Last action

Contract number
75N92019F00074
Awardee
Awarding agency
Obligated
$507,703

Award facts

Opportunity
Contract value 100% obligated
$507,702.77 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Albuquerque, NM 87108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 -$361,100
Funding Only Action P00007 -$334,958
Other Administrative Action P00006 -$29,072
Other Administrative Action P00005 -$55,598
Exercise an Option P00004 $48,415
Exercise an Option P00003 $59,598
Exercise an Option P00002 · Gene therapy resource program (gtrp): pharmacology and toxicology core laboratory scientific activities $397,428
Exercise an Option P00001 $492,274
Original award $290,715

About this award

Written by GovTribe AI ·

This is a $507,702.77 cost-plus-fixed-fee delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the NHLBI's Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories focused on pharmacology and toxicology, preclinical vector development, and a clinical coordinating center. This contract does not have a set-aside designation. Lovelace Biomedical Research Institute has extensive experience supporting federal agencies like the NIH, DoD, and HHS with a range of preclinical research services, including animal studies, analytical testing, and product manufacturing.

Description

As the agency reported it.

The nhlbi requires the gene therapy resource program (gtrp) support translational gene therapy research by providing resources and services from three core laboratories: 1.) pharmacology and toxicology core laboratory, 2.) preclinical vector core laboratory, 3.) clinical coordinating center (CCC), which is not required to have any laboratory capabilities.

Subawards

Subcontractor Amount Awarded
American Foundation For Biological Research STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK ORDER 001 Task Area A: Task Order #00001 will be awarded under Task Area A concurrently with the IDIQ… $9,000
American Foundation For Biological Research STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK ORDER 001 This Task Area will be for 66 months (5.5 years) in total. Each option will involve study… $260,080
Duke University STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK ORDER 001 Through a subcontract arrangement between the Department of Population Health Sciences in the… $35,100
Medstar Health Research Institute Inc. STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK ORDER 001 MHRI will maintain the SHS biorepository of -80C freezers in its current two-site… $480,857
Texas Biomedical Research Institute STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK ORDER 001 Contribute to the organization of and participate collaboratively in the Steering Committee… $469,900
The Medical College Of Wisconsin, Inc. REDS-IV-P DOMESTIC HUBS PHASE 1. Dr. McIntosh is participating in the Phase 3 Peripartum DAR. Her main roles include participating in calls where the design… $54,478
Yale Univ STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC) - TASK ORDER 001 Aim 1: Map SHS SDoH and IDoH elements and allowable response values to existing NIH CDEs… $330,474
Marshfield Clinic, Inc. REDS-IV-P DOMESTIC HUBS PHASE 1. Marshfield Clinic Research Institute will 1) Develop and pilot the IT programs and systems to extract EHR data on patients that… $114,002
Seattle Children's Hospital STRONG HEART STUDY (SHS) - FIELD CENTER, TASK ORDER 001, BASE PERIOD, FEBRUARY 15, 2019 TO FEBRUARY 14, 2020 Dr. Deen will contribute to tribal and community… $173,484

Quick answers

Who was awarded contract 75N92019F00074?

75N92019F00074 was awarded to Lovelace Biomedical Research Institute by National Heart Lung and Blood Institute (National Institutes of Health) on December 19, 2018.

How much is contract 75N92019F00074 worth?

The government has obligated $507,703 on 75N92019F00074.

Is contract 75N92019F00074 an order under another contract?

Yes. 75N92019F00074 is a delivery order under 75N92019D00017, an indefinite delivery contract.

Was contract 75N92019F00074 competed?

The extent of competition for 75N92019F00074 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login